Saba Capital Management’s CERo Therapeutics Holdings, Inc. Warrants CEROW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.04K | Hold |
295,913
| – | – | ﹤0.01% | 272 |
|
2025
Q1 | $3.77K | Hold |
295,913
| – | – | ﹤0.01% | 244 |
|
2024
Q4 | $2.71K | Hold |
295,913
| – | – | ﹤0.01% | 265 |
|
2024
Q3 | $1.75K | Hold |
295,913
| – | – | ﹤0.01% | 334 |
|
2024
Q2 | $5.95K | Hold |
295,913
| – | – | ﹤0.01% | 331 |
|
2024
Q1 | $26.3K | Hold |
295,913
| – | – | ﹤0.01% | 272 |
|
2023
Q4 | $8.14K | Hold |
295,913
| – | – | ﹤0.01% | 387 |
|
2023
Q3 | $22.7K | Hold |
295,913
| – | – | ﹤0.01% | 412 |
|
2023
Q2 | $19.4K | Hold |
295,913
| – | – | ﹤0.01% | 472 |
|
2023
Q1 | $11.9K | Hold |
295,913
| – | – | ﹤0.01% | 656 |
|
2022
Q4 | $12.8K | Hold |
295,913
| – | – | ﹤0.01% | 755 |
|
2022
Q3 | $24K | Hold |
295,913
| – | – | ﹤0.01% | 898 |
|
2022
Q2 | $31K | Hold |
295,913
| – | – | ﹤0.01% | 934 |
|
2022
Q1 | $64K | Hold |
295,913
| – | – | ﹤0.01% | 842 |
|
2021
Q4 | $124K | Buy |
+295,913
| New | +$124K | ﹤0.01% | 682 |
|